chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Asthenia, Fatigue
Clinical narrative: Long term 2 or 3 months extreme weakness after the 2nd shot; Long term 2 or 3 months of extreme fatigue after the 2nd shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Long term 2 or 3 months extreme weakness after the 2nd shot) and FATIGUE (Long term 2 or 3 months of extreme fatigue after the 2nd shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Long term 2 or 3 months extreme weakness after the 2nd shot) and FATIGUE (Long term 2 or 3 months of extreme fatigue after the 2nd shot). At the time of the report, ASTHENIA (Long term 2 or 3 months extreme weakness after the 2nd shot) and FATIGUE (Long term 2 or 3 months of extreme fatigue after the 2nd shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter. No treatment details were provided by the reporter.     Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Hot flush
Clinical narrative: covid vaccine cause you to have hot flashes; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of HOT FLUSH (covid vaccine cause you to have hot flashes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HOT FLUSH (covid vaccine cause you to have hot flashes). At the time of the report, HOT FLUSH (covid vaccine cause you to have hot flashes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  No treatment drugs were reported
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Gait disturbance, Malaise, Pain in extremity
Clinical narrative: I had all the classic symptoms listed; I needed assistance walking; as the bottoms of my feet hurt; and my ankles hurt; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (I had all the classic symptoms listed), GAIT DISTURBANCE (I needed assistance walking), PAIN IN EXTREMITY (as the bottoms of my feet hurt) and ARTHRALGIA (and my ankles hurt) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MALAISE (I had all the classic symptoms listed), GAIT DISTURBANCE (I needed assistance walking), PAIN IN EXTREMITY (as the bottoms of my feet hurt) and ARTHRALGIA (and my ankles hurt). At the time of the report, MALAISE (I had all the classic symptoms listed), GAIT DISTURBANCE (I needed assistance walking), PAIN IN EXTREMITY (as the bottoms of my feet hurt) and ARTHRALGIA (and my ankles hurt) outcome was unknown.            Reporter did not allow further contact
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Headache
Clinical narrative: headache; short of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (short of breath) and HEADACHE (headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination.     Concurrent medical conditions included Urinary tract infection since 15-Apr-2021.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-May-2021, the patient experienced DYSPNOEA (short of breath). On 15-May-2021, the patient experienced HEADACHE (headache). The patient was treated with PHENAZOPYRIDINE on 29-Apr-2021 at a dose of 100 mg three times a day; OXYBUTYNIN on 29-Apr-2021 at a dose of once a day for 14 days; CIPROFLOXACIN on 13-May-2021 at a dose of 500 mg twice a day and MIRABEGRON (MYRBETRIQ) on 13-May-2021 at a dose of once a day for 7 days. On 15-May-2021, DYSPNOEA (short of breath) and HEADACHE (headache) outcome was unknown.            No concomitant medications were reported.  Treatment also include sage juice daily, carrot, lemon, curcuma and ginger juice daily.   This case was linked to MOD-2021-163654 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: TCR contains NNI, where reporter stated she does not have computer and access to email or fax
Sex: M
Vaccine: COVID19
Symptoms: Decreased appetite, Dizziness, Vomiting
Clinical narrative: lost his appetite; constantly dizzy; throwing up everything he eats; This spontaneous case was reported by a consumer and describes the occurrence of DECREASED APPETITE (lost his appetite), DIZZINESS (constantly dizzy) and VOMITING (throwing up everything he eats) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DECREASED APPETITE (lost his appetite), DIZZINESS (constantly dizzy) and VOMITING (throwing up everything he eats). At the time of the report, DECREASED APPETITE (lost his appetite), DIZZINESS (constantly dizzy) and VOMITING (throwing up everything he eats) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. No treatment was reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Strong pain in my arm where I got the shot; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Strong pain in my arm where I got the shot) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported. No concomitant medication reported.     On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Strong pain in my arm where I got the shot). At the time of the report, VACCINATION SITE PAIN (Strong pain in my arm where I got the shot) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication information not provided.  Treatment information not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose fluctuation, Fatigue, Malaise
Clinical narrative: feeling blah (can't do anything); Blood sugar spiking at night /spike in their blood sugar; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (feeling blah (can't do anything)), BLOOD GLUCOSE FLUCTUATION (Blood sugar spiking at night /spike in their blood sugar) and FATIGUE (fatigue) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 029K20A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes. Concomitant products included LISINOPRIL for Blood pressure, INSULIN GLARGINE (LANTUS) and INSULIN LISPRO (LISPRO INSULIN) for Blood sugar abnormal, PANTOPRAZOLE and INSULIN HUMAN, INSULIN HUMAN INJECTION, ISOPHANE (RELION/NOVOLIN) for an unknown indication.   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MALAISE (feeling blah (can't do anything)), BLOOD GLUCOSE FLUCTUATION (Blood sugar spiking at night /spike in their blood sugar) and FATIGUE (fatigue). The patient was treated with LEVOTHYROXINE ongoing since an unknown date for Thyroid disorder NOS, at a dose of 1 dosage form. At the time of the report, MALAISE (feeling blah (can't do anything)), BLOOD GLUCOSE FLUCTUATION (Blood sugar spiking at night /spike in their blood sugar) and FATIGUE (fatigue) had not resolved.            Treatment information was not provided.    Most recent FOLLOW-UP information incorporated above includes: On 23-Jun-2021: Follow-up received on 23-jun-2021 included reporter details. On 30-Jun-2021: Follow up received on 30-jun-2021 included Dose dates and Batch number, Added Concomitants (Pantaprazole, Lantus, Lispro, Lisinopril and Levothyroxine ), Added events Fatigue, Feeling Blah.
Sex: U
Vaccine: COVID19
Symptoms: Ear pain, Lymphadenopathy, Odynophagia
Clinical narrative: ear hurts; hurts to swallow; Lymph node on the left side of my neck swelled up; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (ear hurts), ODYNOPHAGIA (hurts to swallow) and LYMPHADENOPATHY (Lymph node on the left side of my neck swelled up) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Swollen lymph nodes in April 2021.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced LYMPHADENOPATHY (Lymph node on the left side of my neck swelled up). In May 2021, the patient experienced EAR PAIN (ear hurts) and ODYNOPHAGIA (hurts to swallow). At the time of the report, EAR PAIN (ear hurts), ODYNOPHAGIA (hurts to swallow) and LYMPHADENOPATHY (Lymph node on the left side of my neck swelled up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient used antibiotics for treatment.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient received first moderna vaccine on 3/22/2021. Since it has passed; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient received first moderna vaccine on 3/22/2021. Since it has passed) in a 78-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient received first moderna vaccine on 3/22/2021. Since it has passed). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient received first moderna vaccine on 3/22/2021. Since it has passed) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Pain, Peripheral swelling
Clinical narrative: arm is red; swollen; hurts; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (arm is red), PERIPHERAL SWELLING (swollen) and PAIN (hurts) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (arm is red), PERIPHERAL SWELLING (swollen) and PAIN (hurts). At the time of the report, ERYTHEMA (arm is red), PERIPHERAL SWELLING (swollen) and PAIN (hurts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant drugs were reported. No treatment drugs are not provided by reporter.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: had a pretty significant reaction; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (had a pretty significant reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (had a pretty significant reaction). At the time of the report, VACCINATION COMPLICATION (had a pretty significant reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Headache
Clinical narrative: Loss of sense of taste; Headache; This spontaneous case was reported by a pharmacist and describes the occurrence of AGEUSIA (Loss of sense of taste) and HEADACHE (Headache) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033B21A and 045B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-May-2021, the patient experienced AGEUSIA (Loss of sense of taste) and HEADACHE (Headache). At the time of the report, AGEUSIA (Loss of sense of taste) and HEADACHE (Headache) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Skin mass
Clinical narrative: small lump; This spontaneous case was reported by a patient and describes the occurrence of SKIN MASS (small lump) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN MASS (small lump). At the time of the report, SKIN MASS (small lump) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Can nausea be a side effect; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (Can nausea be a side effect) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced NAUSEA (Can nausea be a side effect). At the time of the report, NAUSEA (Can nausea be a side effect) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Neck pain, Vaccination site bruising, Vaccination site haemorrhage, Vaccination site pain
Clinical narrative: It did bleed and bruise; When patient got the vaccine in a blood vessel it did bleed; Pain in my left arm, shoulder and side of neck; patient received the vaccine in a blood vessel; Pain in my left arm, shoulder and side of neck; Pain in my left arm, shoulder and side of neck; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (It did bleed and bruise), VACCINATION SITE HAEMORRHAGE (When patient got the vaccine in a blood vessel it did bleed), NECK PAIN (Pain in my left arm, shoulder and side of neck), PAIN IN EXTREMITY (Pain in my left arm, shoulder and side of neck) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (patient received the vaccine in a blood vessel) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE BRUISING (It did bleed and bruise), VACCINATION SITE HAEMORRHAGE (When patient got the vaccine in a blood vessel it did bleed), NECK PAIN (Pain in my left arm, shoulder and side of neck), PAIN IN EXTREMITY (Pain in my left arm, shoulder and side of neck), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (patient received the vaccine in a blood vessel) and ARTHRALGIA (Pain in my left arm, shoulder and side of neck). At the time of the report, VACCINATION SITE BRUISING (It did bleed and bruise), VACCINATION SITE HAEMORRHAGE (When patient got the vaccine in a blood vessel it did bleed), NECK PAIN (Pain in my left arm, shoulder and side of neck), PAIN IN EXTREMITY (Pain in my left arm, shoulder and side of neck), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (patient received the vaccine in a blood vessel) and ARTHRALGIA (Pain in my left arm, shoulder and side of neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Wrong technique in product usage process
Clinical narrative: It did bleed and bruise; When patient got the vaccine in a blood vessel it did bleed; Pain in my left arm, shoulder and side of neck; patient received the vaccine in a blood vessel; Pain in my left arm, shoulder and side of neck; Pain in my left arm, shoulder and side of neck; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE BRUISING (It did bleed and bruise), VACCINATION SITE HAEMORRHAGE (When patient got the vaccine in a blood vessel it did bleed), NECK PAIN (Pain in my left arm, shoulder and side of neck), PAIN IN EXTREMITY (Pain in my left arm, shoulder and side of neck) and WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (patient received the vaccine in a blood vessel) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE BRUISING (It did bleed and bruise), VACCINATION SITE HAEMORRHAGE (When patient got the vaccine in a blood vessel it did bleed), NECK PAIN (Pain in my left arm, shoulder and side of neck), PAIN IN EXTREMITY (Pain in my left arm, shoulder and side of neck), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (patient received the vaccine in a blood vessel) and ARTHRALGIA (Pain in my left arm, shoulder and side of neck). At the time of the report, VACCINATION SITE BRUISING (It did bleed and bruise), VACCINATION SITE HAEMORRHAGE (When patient got the vaccine in a blood vessel it did bleed), NECK PAIN (Pain in my left arm, shoulder and side of neck), PAIN IN EXTREMITY (Pain in my left arm, shoulder and side of neck), WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (patient received the vaccine in a blood vessel) and ARTHRALGIA (Pain in my left arm, shoulder and side of neck) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: hair loss; This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (hair loss) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced ALOPECIA (hair loss). At the time of the report, ALOPECIA (hair loss) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: Fever; Chills; Soreness; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Soreness) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.   In April 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-May-2021, the patient experienced PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Soreness). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, PYREXIA (Fever), CHILLS (Chills) and MYALGIA (Soreness) outcome was unknown.            This case was linked to MOD-2021-163710 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Candida infection
Clinical narrative: Thrush; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CANDIDA INFECTION (Thrush) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CANDIDA INFECTION (Thrush). At the time of the report, CANDIDA INFECTION (Thrush) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pain, Swelling, Vaccination site pain
Clinical narrative: swelled up to 4 inch long and 3 inch wide; red; feels warm when touched in the middle; sore; swelling at the injection site; hurts; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE SWELLING (swelling at the injection site), PAIN (hurts), SWELLING (swelled up to 4 inch long and 3 inch wide), ERYTHEMA (red) and FEELING HOT (feels warm when touched in the middle) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Diabetes.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling at the injection site), PAIN (hurts), SWELLING (swelled up to 4 inch long and 3 inch wide), ERYTHEMA (red), FEELING HOT (feels warm when touched in the middle) and PAIN (sore). At the time of the report, VACCINATION SITE SWELLING (swelling at the injection site), PAIN (hurts), SWELLING (swelled up to 4 inch long and 3 inch wide), ERYTHEMA (red), FEELING HOT (feels warm when touched in the middle) and PAIN (sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment information provided.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: swelled up to 4 inch long and 3 inch wide; red; feels warm when touched in the middle; sore; swelling at the injection site; hurts; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE SWELLING (swelling at the injection site), PAIN (hurts), SWELLING (swelled up to 4 inch long and 3 inch wide), ERYTHEMA (red) and FEELING HOT (feels warm when touched in the middle) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Asthma and Diabetes.    On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (swelling at the injection site), PAIN (hurts), SWELLING (swelled up to 4 inch long and 3 inch wide), ERYTHEMA (red), FEELING HOT (feels warm when touched in the middle) and PAIN (sore). At the time of the report, VACCINATION SITE SWELLING (swelling at the injection site), PAIN (hurts), SWELLING (swelled up to 4 inch long and 3 inch wide), ERYTHEMA (red), FEELING HOT (feels warm when touched in the middle) and PAIN (sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment information provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Pyrexia, Vaccination site pain
Clinical narrative: diziness 1st dose; fever 1st dose; tiredness1st dose; headache1st dose; lot of arm pain 1st; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (diziness 1st dose), PYREXIA (fever 1st dose), FATIGUE (tiredness1st dose), HEADACHE (headache1st dose) and VACCINATION SITE PAIN (lot of arm pain 1st) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044A21A and 021B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in November 2020.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DIZZINESS (diziness 1st dose), PYREXIA (fever 1st dose), FATIGUE (tiredness1st dose), HEADACHE (headache1st dose) and VACCINATION SITE PAIN (lot of arm pain 1st). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, DIZZINESS (diziness 1st dose), PYREXIA (fever 1st dose), FATIGUE (tiredness1st dose), HEADACHE (headache1st dose) and VACCINATION SITE PAIN (lot of arm pain 1st) outcome was unknown.            No concomitant medications were provided.   This case was linked to MOD-2021-163717 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: nauseated; throwing up; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseated) and VOMITING (throwing up) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No medical history was reported.     On 23-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-May-2021, the patient experienced NAUSEA (nauseated) and VOMITING (throwing up). At the time of the report, NAUSEA (nauseated) and VOMITING (throwing up) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment medications were not reported.   Reporter did not allow further contact
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature fluctuation, Freezing phenomenon, Hyperhidrosis, Impaired work ability, Nervousness
Clinical narrative: His temperaturee at this time was 91.1/ his temperature was 100.8/ Since the vaccine his temperature is 96 or below/ His temperature during the call was 97.1; Effecting his work; He was not shivering but having whole body shuddering; Sweating; Left eye vision doesn't seem distinct; Freezing; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR DISCOMFORT (Left eye vision doesn't seem distinct), FREEZING PHENOMENON (Freezing), NERVOUSNESS (He was not shivering but having whole body shuddering), HYPERHIDROSIS (Sweating) and BODY TEMPERATURE FLUCTUATION (His temperaturee at this time was 91.1/ his temperature was 100.8/ Since the vaccine his temperature is 96 or below/ His temperature during the call was 97.1) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027b21a and 003b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to antibiotic (Allergic to Doxycycline series antibiotics) and Drug allergy (Morphine). Concomitant products included OMEPRAZOLE, CEFADROXIL and FENTANYL for an unknown indication.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced OCULAR DISCOMFORT (Left eye vision doesn't seem distinct) and FREEZING PHENOMENON (Freezing). On 20-Apr-2021, the patient experienced NERVOUSNESS (He was not shivering but having whole body shuddering) and HYPERHIDROSIS (Sweating). On an unknown date, the patient experienced BODY TEMPERATURE FLUCTUATION (His temperaturee at this time was 91.1/ his temperature was 100.8/ Since the vaccine his temperature is 96 or below/ His temperature during the call was 97.1) and IMPAIRED WORK ABILITY (Effecting his work). At the time of the report, OCULAR DISCOMFORT (Left eye vision doesn't seem distinct), FREEZING PHENOMENON (Freezing), NERVOUSNESS (He was not shivering but having whole body shuddering), HYPERHIDROSIS (Sweating), BODY TEMPERATURE FLUCTUATION (His temperaturee at this time was 91.1/ his temperature was 100.8/ Since the vaccine his temperature is 96 or below/ His temperature during the call was 97.1) and IMPAIRED WORK ABILITY (Effecting his work) outcome was unknown.            Treatment medications were unknown.    This case was linked to MOD-2021-163566 (Patient Link).
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Ocular discomfort
Clinical narrative: His temperaturee at this time was 91.1/ his temperature was 100.8/ Since the vaccine his temperature is 96 or below/ His temperature during the call was 97.1; Effecting his work; He was not shivering but having whole body shuddering; Sweating; Left eye vision doesn't seem distinct; Freezing; This spontaneous case was reported by a consumer and describes the occurrence of OCULAR DISCOMFORT (Left eye vision doesn't seem distinct), FREEZING PHENOMENON (Freezing), NERVOUSNESS (He was not shivering but having whole body shuddering), HYPERHIDROSIS (Sweating) and BODY TEMPERATURE FLUCTUATION (His temperaturee at this time was 91.1/ his temperature was 100.8/ Since the vaccine his temperature is 96 or below/ His temperature during the call was 97.1) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027b21a and 003b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy to antibiotic (Allergic to Doxycycline series antibiotics) and Drug allergy (Morphine). Concomitant products included OMEPRAZOLE, CEFADROXIL and FENTANYL for an unknown indication.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Mar-2021, the patient experienced OCULAR DISCOMFORT (Left eye vision doesn't seem distinct) and FREEZING PHENOMENON (Freezing). On 20-Apr-2021, the patient experienced NERVOUSNESS (He was not shivering but having whole body shuddering) and HYPERHIDROSIS (Sweating). On an unknown date, the patient experienced BODY TEMPERATURE FLUCTUATION (His temperaturee at this time was 91.1/ his temperature was 100.8/ Since the vaccine his temperature is 96 or below/ His temperature during the call was 97.1) and IMPAIRED WORK ABILITY (Effecting his work). At the time of the report, OCULAR DISCOMFORT (Left eye vision doesn't seem distinct), FREEZING PHENOMENON (Freezing), NERVOUSNESS (He was not shivering but having whole body shuddering), HYPERHIDROSIS (Sweating), BODY TEMPERATURE FLUCTUATION (His temperaturee at this time was 91.1/ his temperature was 100.8/ Since the vaccine his temperature is 96 or below/ His temperature during the call was 97.1) and IMPAIRED WORK ABILITY (Effecting his work) outcome was unknown.            Treatment medications were unknown.    This case was linked to MOD-2021-163566 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Adverse reaction, SARS-CoV-2 antibody test, SARS-CoV-2 test
Clinical narrative: minor reaction; This spontaneous case was reported by a consumer and describes the occurrence of ADVERSE REACTION (minor reaction) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in October 2020.    On 01-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced ADVERSE REACTION (minor reaction). At the time of the report, ADVERSE REACTION (minor reaction) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In October 2020, SARS-CoV-2 test: positive Positive. In November 2020, SARS-CoV-2 antibody test: positive Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment information not provided   Reporter did not allow further contact
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Dizziness, Ear discomfort, Ear pain, Fatigue
Clinical narrative: pain in nasal area not navel; nauseas; feeling dizzy; it didn't feel right; ears still hurt; Felt fatigue, tired the whole day; Arm was sore; too sick to call; pain/pressure in her navel area; pain/pressure in ears; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (too sick to call), ABDOMINAL PAIN (pain/pressure in her navel area), EAR PAIN (pain/pressure in ears), DIZZINESS (feeling dizzy) and FEELING ABNORMAL (it didn't feel right) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included IRON for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced ILLNESS (too sick to call), ABDOMINAL PAIN (pain/pressure in her navel area) and EAR PAIN (pain/pressure in ears). On 03-Apr-2021, the patient experienced FATIGUE (Felt fatigue, tired the whole day) and VACCINATION SITE PAIN (Arm was sore). On 04-Apr-2021, the patient experienced DIZZINESS (feeling dizzy), FEELING ABNORMAL (it didn't feel right), EAR DISCOMFORT (ears still hurt) and NAUSEA (nauseas). On an unknown date, the patient experienced RHINALGIA (pain in nasal area not navel). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]) at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, ILLNESS (too sick to call), ABDOMINAL PAIN (pain/pressure in her navel area), DIZZINESS (feeling dizzy), FEELING ABNORMAL (it didn't feel right), EAR DISCOMFORT (ears still hurt), VACCINATION SITE PAIN (Arm was sore) and NAUSEA (nauseas) outcome was unknown and EAR PAIN (pain/pressure in ears), RHINALGIA (pain in nasal area not navel) and FATIGUE (Felt fatigue, tired the whole day) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Event update/correction/event outcome : patient has clarified that she was suffering from Nasal Pain and not navel pain.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Illness, Nausea, Rhinalgia, Vaccination site pain
Clinical narrative: pain in nasal area not navel; nauseas; feeling dizzy; it didn't feel right; ears still hurt; Felt fatigue, tired the whole day; Arm was sore; too sick to call; pain/pressure in her navel area; pain/pressure in ears; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (too sick to call), ABDOMINAL PAIN (pain/pressure in her navel area), EAR PAIN (pain/pressure in ears), DIZZINESS (feeling dizzy) and FEELING ABNORMAL (it didn't feel right) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included IRON for an unknown indication.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced ILLNESS (too sick to call), ABDOMINAL PAIN (pain/pressure in her navel area) and EAR PAIN (pain/pressure in ears). On 03-Apr-2021, the patient experienced FATIGUE (Felt fatigue, tired the whole day) and VACCINATION SITE PAIN (Arm was sore). On 04-Apr-2021, the patient experienced DIZZINESS (feeling dizzy), FEELING ABNORMAL (it didn't feel right), EAR DISCOMFORT (ears still hurt) and NAUSEA (nauseas). On an unknown date, the patient experienced RHINALGIA (pain in nasal area not navel). The patient was treated with ACETYLSALICYLIC ACID, CAFFEINE, PARACETAMOL (EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]) at an unspecified dose and frequency; CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at an unspecified dose and frequency. At the time of the report, ILLNESS (too sick to call), ABDOMINAL PAIN (pain/pressure in her navel area), DIZZINESS (feeling dizzy), FEELING ABNORMAL (it didn't feel right), EAR DISCOMFORT (ears still hurt), VACCINATION SITE PAIN (Arm was sore) and NAUSEA (nauseas) outcome was unknown and EAR PAIN (pain/pressure in ears), RHINALGIA (pain in nasal area not navel) and FATIGUE (Felt fatigue, tired the whole day) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No Concomitant medications were reported by the reporter.    Most recent FOLLOW-UP information incorporated above includes: On 24-Jul-2021: Event update/correction/event outcome : patient has clarified that she was suffering from Nasal Pain and not navel pain.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: diagnosed with COVID19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (diagnosed with COVID19) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-May-2021, the patient experienced COVID-19 (diagnosed with COVID19). At the time of the report, COVID-19 (diagnosed with COVID19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment information provided.
Sex: U
Vaccine: COVID19
Symptoms: Joint swelling, Peripheral swelling
Clinical narrative: leg, feet, and ankle swelling; leg, feet, and ankle swelling; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (leg, feet, and ankle swelling) and JOINT SWELLING (leg, feet, and ankle swelling) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (leg, feet, and ankle swelling) and JOINT SWELLING (leg, feet, and ankle swelling). At the time of the report, PERIPHERAL SWELLING (leg, feet, and ankle swelling) and JOINT SWELLING (leg, feet, and ankle swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported  No treatment drugs were provided
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: First dose over 95 days ago; This spontaneous case was reported by a health care professional and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (First dose over 95 days ago) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Myocardial infarction. Concomitant products included CLOPIDOGREL BISULFATE (PLAVIX) from December 2020 to an unknown date, ATORVASTATIN CALCIUM (LIPITOR) from December 2020 to an unknown date and ASPIRIN [ACETYLSALICYLIC ACID] from December 2020 to an unknown date for Myocardial infarction.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PRODUCT DOSE OMISSION ISSUE (First dose over 95 days ago). At the time of the report, PRODUCT DOSE OMISSION ISSUE (First dose over 95 days ago) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   This case was linked to MOD-2021-241054 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: Additional information received included patient demographic details which included race, ethnicity, height and weight; relevant medical history details which included acute mild myocardial infarction; concomitant medication details including Plavix, Lipitor and aspirin; suspect vaccine details which included route of vaccine administered and re-challenge details.
Sex: U
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: itching at the injection site; swelling at the injection site; redness at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PRURITUS (itching at the injection site), INJECTION SITE SWELLING (swelling at the injection site) and INJECTION SITE ERYTHEMA (redness at the injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PRURITUS (itching at the injection site), INJECTION SITE SWELLING (swelling at the injection site) and INJECTION SITE ERYTHEMA (redness at the injection site). At the time of the report, INJECTION SITE PRURITUS (itching at the injection site), INJECTION SITE SWELLING (swelling at the injection site) and INJECTION SITE ERYTHEMA (redness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  Treatment medications were not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Sciatica
Clinical narrative: sciatic nerve pain; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 23-May-2021 and was forwarded to Moderna on 24-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of SCIATICA (sciatic nerve pain) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SCIATICA (sciatic nerve pain). At the time of the report, SCIATICA (sciatic nerve pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Treatment Medications were reported. No concomitant medication details were reported.    Reporter did not allow further contact